Grand Yangtze Capital

company

About

Grand Yangtze Capital is a professional equity investment management organization.

  • 11 - 50

Highlights

Details

Industries
Financial Services
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB.

Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc.

Investments

Number of Investments
Number of Lead Investments
1
0
Grand Yangtze Capital has made 1 investments. Their most recent investment was on Sep 4, 2020, when InxMed raised ¥130M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 4, 2020 InxMed
Series A ¥130M Biotechnology